시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 소아 관류 시장 규모, 점유율, 산업 동향 분석 리포트 : 최종 용도별, 제품별, 지역별 전망과 예측(2023-2030년)
Global Pediatric Perfusion Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Cardiac Centers, and Others), By Product, By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1384977
리서치사 : KBV Research
발행일 : 2023년 10월
페이지 정보 : 영문 227 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 5,085,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 6,102,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,542,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

소아 관류 시장 규모는 2030년까지 8억 180만 달러에 달하며, 예측 기간 중 CAGR 5.8%의 시장 성장률로 상승할 것으로 예측됩니다.

그러나 소아 관류 전문의와 특수 관류 장비와 같은 의료 자원과 인력 부족도 접근성에 악영향을 미칩니다. 자원이 부족한 지역에서는 소아 심장 수술 및 관류 서비스 예약이 적어 대기 시간이 길어질 수 있습니다. 이는 치료의 질에 영향을 미칠 뿐만 아니라 가족의 스트레스와 불안을 증가시킵니다. 또한 전문 자원의 부족은 의료 서비스 프로바이더에게 부담을 주며 시장 성장 잠재력을 더욱 저해할 것입니다.

또한 COVID-19 진료에 대한 인력 및 장비 할당과 같은 전염병으로 인한 의료 자원의 왜곡은 소아 심장 치료를 포함한 비(非)COVID-19 관련 의료에도 악영향을 미쳤습니다. 일부 소아 심장 수술 및 시술이 연기되거나 일정이 변경되어 관류 기술자의 일정과 업무량에 영향을 미쳤습니다. 일부 의료 시설에서는 바이러스 감염에 대한 우려와 폐쇄 조치로 인해 팬데믹 기간 중 환자 수가 감소했습니다. 이러한 환자 수의 감소는 이러한 서비스 및 장비에 대한 수요 감소로 이어졌습니다.

최종 용도 전망

최종 용도별로 시장은 병원, 심장 센터 및 기타로 분류되며, 심장 센터 부문은 2022년 시장에서 큰 매출 점유율을 차지할 것으로 예상됩니다. 심장 센터는 일반적으로 어린 환자의 고유한 요구를 관리한 경험이 풍부한 고도로 전문화된 소아 관류 전문가를 고용합니다. 이 전문가들은 소아 심장 수술의 복잡성을 이해하고 있으므로 소아 심장 수술 중 관류의 미묘한 뉘앙스를 다룰 수 있는 충분한 장비를 갖추고 있습니다. 심장센터에는 소아 환자의 특수한 요구를 충족시키기 위해 설계된 최첨단 관류 장비가 구비되어 있습니다. 여기에는 소아에게 적합한 특수 산소 공급기, 캐뉼라, 모니터링 시스템 등이 포함됩니다.

제품 전망

제품별로 시장은 소아용 산소 공급기, 소아용 캐뉼라, 소아용 혈액 펌프, 소아용 동맥 필터, 모니터링 시스템 및 기타로 나뉩니다. 모니터링 시스템 부문은 2022년 시장에서 유망한 성장률을 확보했습니다. 소아 관류 모니터링 시스템 부문은 환자의 안전을 우선시하고 기술 발전을 활용하여 심장 수술 중 실시간 데이터와 함께 피드백을 제공함으로써 성장을 주도하고 있습니다. 이 부문의 성장은 심장 수술 건수 증가, 규제 기준 준수, 지속적인 모니터링에 대한 요구 증가에 기인합니다.

지역별 전망

지역별로는 북미, 유럽, 아시아태평양, LAMEA로 시장을 분석합니다. 아시아태평양은 2022년 시장 성장률이 두드러지는데, 높은 CVD 유병률과 첨단화된 의료 인프라가 성장의 요인으로 작용할 것으로 보입니다. 또한 이 지역에는 여러 정부 구상이 있으므로 시장 성장도 기대할 수 있습니다. 막대한 R&D 투자, 장려적인 정부 정책, CPB 장비에 대한 사회적 인식 개선이 시장 성장에 기여하고 있습니다. 이러한 요인으로 인해 CPB 장비에 대한 수요와 채택이 증가하고 있으며, 이는 이 지역의 전체 시장 성장을 가속하고 있습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장의 개요

제3장 시장 개요

제4장 소아 관류 시장에서 도입되는 전략

제5장 세계의 소아 관류 시장 : 최종 용도별

제6장 세계의 소아 관류 시장 : 제품별

제7장 세계의 소아 관류 시장 : 지역별

제8장 기업 개요

제9장 시장의 성공 필수 조건

KSA
영문 목차

영문목차

The Global Pediatric Perfusion Market size is expected to reach $801.8 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period.

The Children's Hospital Graduate Medical Education (CHGME) Program and National Congenital Heart Disease Action Plan have aided in increasing the awareness of CHD in newborns. Therefore, Hospitals segment generated $3,95.1 million revenue in the market in 2022. As a result, the CHGME program also provides federal funding to children's hospitals for graduate medical education. It supports the training of pediatric perfusionists and healthcare professionals specializing in pediatric cardiac care. Some of the factors impacting the market are rising R&D and multidisciplinary approach towards patient care, increasing incidence of congenital heart defects and limited accessibility to specialized care.

The positive impact of a multidisciplinary approach is further complemented by ongoing research and development in the field. Research initiatives aim to explore new techniques, technologies, and best practices that can enhance the safety and efficacy of pediatric perfusion. These efforts have led to the creation of more advanced and efficient perfusion equipment and techniques, driving further growth in the market. Additionally, CHDs are structural heart abnormalities that are present at birth and often require surgical intervention, making pediatric perfusion services a crucial component of the care provided to these young patients. According to the National Library of Medicine, the birth prevalence of CHD varies among studies worldwide and is mostly reported between 8 and 12 per 1000. Therefore, all these aforementioned factors will aid in the expansion of the market in the coming years and the combined effect of these factors has transformed the landscape of pediatric cardiac care, with pediatric perfusionists playing a central role in ensuring the well-being of children with congenital heart defects.

However, the scarcity of healthcare resources and personnel, such as pediatric perfusionists and specialized perfusion equipment, also plays a detrimental role in accessibility. In regions with limited resources, there may be fewer available appointments for pediatric cardiac surgeries and perfusion services, leading to prolonged wait times. This not only affects the quality of care but also increases stress and uncertainty for families. Moreover, the shortage of specialized resources can place a strain on healthcare providers, further hampering the market's growth potential.

Additionally, the strain on healthcare resources due to the pandemic, such as the allocation of staff and equipment to COVID-19 care, had negative implications for non-COVID-related healthcare, including pediatric cardiac care. Some pediatric cardiac surgeries and procedures were delayed or rescheduled, impacting the scheduling and workloads of perfusionists. Some healthcare facilities experienced a reduction in patient volumes during the pandemic due to concerns about virus transmission and lockdown measures. This reduced patient volume led to decreased demand for these services and equipment.

End Use Outlook

On the basis of end-use, the market is segmented into hospitals, cardiac centers, and others. The cardiac centers segment witnessed a significant revenue share in the market in 2022. Cardiac centers typically employ highly specialized pediatric perfusionists who have extensive experience in managing the unique needs of young patients. These professionals understand the complexities of pediatric cardiac surgery, making them well-equipped to handle the nuances of perfusion during these procedures. Cardiac centers are equipped with state-of-the-art perfusion equipment designed to cater to the unique needs of pediatric patients. This includes specialized oxygenators, cannulae, and monitoring systems suitable for children.

Product Outlook

Based on product, the market is divided into pediatric oxygenators, pediatric cannulae, pediatric blood pumps, pediatric arterial filters, monitoring systems, and others. The monitoring systems segment procured a promising growth rate in the market in 2022. By prioritizing patient safety and taking advantage of technological advancements, the pediatric perfusion monitoring systems segment drives growth by offering real-time data along with feedback during cardiac surgeries. The segment's growth is attributed to the growing number of heart surgeries, regulatory standard compliance, and the growing need for continuous monitoring.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region procured a remarkable growth rate in the market in 2022. High CVD prevalence and an advanced healthcare infrastructure are responsible for this growth. The market is also expected to grow as a result of several government initiatives in this region. Significant R&D investments, encouraging government policies, and rising public awareness of CPB machines contribute to the market's growth. Owing to these factors, there is a growing need for and adoption of CPB machines, which propels the regional market's overall growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.

Strategies Deployed in Pediatric Perfusion Market

Aug-2023: Medtronic PLC came into partnership with Cydar Medical, a UK-based medical Equipment Manufacturing company. Through this partnership, Medtronic PLC would focus on bolstering exceptional service and assistance to healthcare professionals, ensuring the validation of long-term predictive abilities, and advancing patient care.

Feb-2023: Koninklijke Philips N.V. came into partnership with TriHealth, a unified health system based in Cincinnati, Ohio, United States. Through this partnership, TriHealth would enhance its cardiac care services and fulfill its commitment to the local community, by offering top-notch healthcare, working in the best interests of the community, collaborating with physicians and other healthcare providers to streamline health services, and contributing to the education of future healthcare professionals.

Aug-2022: Medtronic PLC came into partnership with BioIntelliSense, a US-based medical device company. This partnership would enable Medtronic's Patient Monitoring division to offer a medical-grade device that will provide ongoing vital sign monitoring for patients receiving general care within the hospital and after discharge.

Oct-2021: Koninklijke Philips N.V. unveiled a comprehensive solution called "Philips Pediatric Coaching," which aims to create a more relaxed and comfortable experience for parents and their children who are going through MRI scans.

Sep-2021: Terumo Corporation came into partnership with Etiometry, a US-based Hospital and Health Care company. Through this partnership, Terumo Corporation would aim to provide state-of-the-art clinical decision support for adults undergoing cardiac surgery, both during the surgical procedure and throughout their post-surgery recovery period.

Mar-2021: Koninklijke Philips N.V. came into Partnership with DiA Imaging Analysis Ltd, a hospital and Healthcare company. Through this partnership, Koninklijke Philips N.V. would provide an unmatched level of diagnostic certainty and streamline operational effectiveness in point-of-care ultrasound imaging. Additionally, this partnership also extends the reach of superior and timely healthcare, both within and beyond hospital settings.

Feb-2021: Terumo Corporation took over Health Outcomes Sciences, Inc. (HOS), a Pharmaceutical Manufacturing company. Through this acquisition, Terumo Corporation would focus on Expanding its footprint in the digital healthcare sector offers a promising avenue for the company's growth.

Scope of the Study

Market Segments covered in the Report:

By End Use

By Product

By Geography

Companies Profiled

Unique Offerings from KBV Research

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Strategies Deployed in Pediatric Perfusion Market

Chapter 5. Global Pediatric Perfusion Market by End-use

Chapter 6. Global Pediatric Perfusion Market by Product

Chapter 7. Global Pediatric Perfusion Market by Region

Chapter 8. Company Profiles

Chapter 9. Wining Imperative for Pediatric Perfusion Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기